6533b854fe1ef96bd12aeb98
RESEARCH PRODUCT
Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal Antibodies
Anne Laure ClairetAna BerceanuLaurie SpehnerEtienne DaguindauSolène Marty-quinternetKarine LacombeBenoit BaillyKevin BouillerJean-laurent CasanovaJulien PuechSandrine ImbeaudQuentin LepillerMarie KroemerPauline RouxBrigitte AutranCatherine ChirouzeXavier De LamballerieDavid VeyerPaul BastardPaul BastardPaul BastardFanny Angelot DelettreOlivier HermineHélène PéréNicolas Robillardsubject
Microbiology (medical)0303 health sciences2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)030306 microbiologybusiness.industryHost (biology)medicine.drug_classSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[SDV]Life Sciences [q-bio]Monoclonal antibodyVirology03 medical and health sciences0302 clinical medicineInfectious DiseasesMedicine030212 general & internal medicinebusinessdescription
International audience; No abstract available
year | journal | country | edition | language |
---|---|---|---|---|
2022-05-01 |